Wissenschaftliche Arbeiten

Doç. Dr. Nalan Ogan

78 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Evaluation of Microplastic Density in Bronchoalveolar Lavage Fluid of Newly Diagnosed Lung Cancer Patients: A Prospective Observational Controlled Study

    2026

    DOI 10.2139/ssrn.6883835 Quelle: ORCID

  2. PREVALENCE AND CLINICAL CHARACTERISTICS OF LUNG CANCER IN ELDERY PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

    Turkish Journal of Geriatrics, 2026

    DOI 10.29400/tjgeri.2026.487 Frei zugänglicher VolltextQuelle: ORCID

  3. Serum paraoxonase-1 as a marker of oxidative stress and pulmonary dysfunction in sarcoidosis: association with disease activity and prognostic potential

    Frontiers in Immunology, 2026

    DOI 10.3389/fimmu.2025.1731991 PMID 41601643 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  4. Evaluation of Microplastic Density in Bronchoalveolar Lavage Fluid of Newly Diagnosed Lung Cancer Patients: A Prospective Observational Controlled Study

    Research Square, 2026

    DOI 10.21203/rs.3.rs-10095928/v1 Frei zugänglicher VolltextQuelle: OpenAlex

  5. Predictors of Diffusion Capacity through Cardiopulmonary Exercise Testing Parameters in Patients with Fibrotic Interstitial Lung Disease: A Pilot Study

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa2692 Quelle: OpenAlex

  6. Is Heart Rate Recovery an Independent Marker of Exacerbation Risk in Stable COPD?

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa4316 Quelle: OpenAlex

  7. Inhaler Adherence and Treatment Behaviors in COPD: A Study from Both Sides of the Aegean Sea

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2026

    DOI 10.1177/19412711261452804 PMID 42187273 Quelle: OpenAlex

  8. Splenic Silicosis Accompanying Chronic Complicated Silicosis: A Rare Systemic Manifestation of Silica Exposure – A Case Report

    Indian Journal of Occupational and Environmental Medicine, 2026

    DOI 10.4103/ijoem.ijoem_278_25 PMID 42872257 Frei zugänglicher VolltextQuelle: OpenAlex

  9. Clinical characteristics and mortality risk factors in COVID-19 patients with pulmonary embolism

    Journal of Pulmonology and Intensive Care, 2026

    DOI 10.51271/jopic-0090 Frei zugänglicher VolltextQuelle: OpenAlex

  10. Association between idiopathic pulmonary fibrosis and lung cancer

    Journal of Pulmonology and Intensive Care, 2025

    DOI 10.51271/jopic-0049 Frei zugänglicher VolltextQuelle: ORCID

  11. Association of Heart Rate Recovery (HRR) with Pulmonary Function Tests and Clinical Indicators in Patients with Stable COPD

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa1404 Quelle: OpenAlex

  12. The effect of intravenous low-dose thrombolytics on in-hospital mortality in patients with intermediate-high-risk pulmonary embolism

    Tuberk Toraks, 2025

    DOI 10.5578/tt.2025041198 PMID 41486791 Frei zugänglicher VolltextQuelle: ORCID

  13. A case of desquamative interstitial pneumonia with unidentified etiology

    Journal of Pulmonology and Intensive Care, 2025

    DOI 10.51271/jopic-0065 Frei zugänglicher VolltextQuelle: ORCID

  14. COPET study findings regarding the clinical relevance of biomass exposure as an etiotype in COPD

    The American Journal of the Medical Sciences, 2025

    DOI 10.1016/j.amjms.2025.07.001 PMID 40645336 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  15. Inhaler Device Use And Treatment Compliance On Opposite Sides Of The Aegean Sea

    European Respiratory Journal, 2025

    DOI 10.1183/13993003.congress-2025.pa2567 Quelle: OpenAlex

  16. Pulmonary Physician Consultancy in Emergency Services in Turkiye (PuPCEST) – a cross-sectional multicenter study

    Medicine, 2024

    DOI 10.1097/md.0000000000037165 PMID 38335404 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  17. Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): which one may be the first option in group A COPD patients?

    European Journal of Clinical Pharmacology, 2024

    DOI 10.1007/s00228-024-03637-1 PMID 38396308 2 Zitationen (Europe PMC) Quelle: ORCID

  18. Can the ADO Index Be Used as a Predictor of Mortality from COVID-19 in Patients with COPD?

    International Journal of Chronic Obstructive Pulmonary Disease, 2024

    DOI 10.2147/copd.s440099 PMID 38596202 Frei zugänglicher VolltextQuelle: ORCID

  19. Effect of alpha-1 antitrypsin and alpha-1-acid glycoprotein levels on prognosis in patients with COPD exacerbation and COPD-community-acquired pneumonia

    Journal of Pulmonology and Intensive Care, 2024

    DOI 10.51271/jopic-0026 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  20. Chronic pulmonary thromboembolic disease

    Journal of Pulmonology and Intensive Care, 2023

    DOI 10.51271/jopic-0016 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  21. Effectiveness of multimedia-assisted training on inhaler usage technique, which is the optimum technique?

    PubMed, 2023

    DOI 10.26355/eurrev_202310_34123 PMID 37916317 1 Zitation (OpenAlex) Quelle: OpenAlex

  22. Characteristics of our hypoxemic COVID-19 pneumonia patients receiving corticosteroids and mortality-associated factors

    Expert Review of Respiratory Medicine, 2022

    DOI 10.1080/17476348.2022.2102480 PMID 35839345 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  23. Chronic obstructive pulmonary disease phenotypes in Turkey: the COPET study—a national, multicenter cross-sectional observational study

    Turkish Journal of Medical Sciences, 2022

    DOI 10.55730/1300-0144.5416 PMID 36326395 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  24. Serum albumin and C-reactive protein/albumin ratio in community-acquired pneumonia

    Journal of Medicine and Palliative Care, 2022

    DOI 10.47582/jompac.1128249 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  25. Evaluation of Exudative Pleural Effusions: A Multicenter, Prospective, Observational Study

    Lung, 2022

    DOI 10.1007/s00408-022-00573-8 PMID 36173482 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  26. The association between total cholesterol and cognitive impairment in chronic obstructive pulmonary disease patients

    Prostaglandins & Other Lipid Mediators, 2022

    DOI 10.1016/j.prostaglandins.2022.106697 PMID 36347442 6 Zitationen (OpenAlex) Quelle: OpenAlex

  27. Telemedicine implementation for management of COVID-19 patients at hospital admission: a single center experience

    European Respiratory Journal, 2022

    DOI 10.1183/13993003.congress-2022.2785 Quelle: OpenAlex

  28. Clinical course of Covid-19 cases vaccinated or unvaccinated

    European Respiratory Journal, 2022

    DOI 10.1183/13993003.congress-2022.3805 Quelle: OpenAlex

  29. KOAH’ta Sanal İnhaler Eğitim Başarılı Mıdır? Randomize Kontrollü Çalışma

    AYBU AVESIS, 2022

    Quelle: OpenAlex

  30. KORTIKOSTEROID KULLANILAN HIPOKSEMIK COVİD-19 PNÖMONILIOLGULARIMIZIN ÖZELLIKLERI VE MORTALITE ILE İLIŞKILI FAKTÖRLER

    Çanakkale Onsekiz Mart University AVESIS, 2021

    Quelle: OpenAlex

  31. Inactive SARS-COV-2 Vaccine Adverse Effects Among Hospital Workers

    Journal of International Health Sciences and Management, 2021

    DOI 10.48121/jihsam.950805 Frei zugänglicher VolltextQuelle: ORCID

  32. Subacute Lung Injury Associated with Heated Tobacco Products

    Düzce Tıp Fakültesi Dergisi, 2021

    DOI 10.18678/dtfd.896093 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  33. Characteristics of hospitalised COVID‐19 patients and parameters associated with severe pneumonia

    International Journal of Clinical Practice, 2021

    DOI 10.1111/ijcp.14786 PMID 34480831 10 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  34. The role of serum HLD, LDL, and uric acid levels in predicting the prognosis of community-acquired pneumonia

    Pamukkale Medical Journal, 2021

    DOI 10.31362/patd.870392 Frei zugänglicher VolltextQuelle: OpenAlex

  35. Characteristics of hospitalized COVID-19 patients and parameters associated with severe pneumonia

    European Respiratory Journal, 2021

    DOI 10.1183/13993003.congress-2021.pa3254 Frei zugänglicher VolltextQuelle: OpenAlex

  36. The effect of the novel type coronavirus infection on the mental health of the patients

    European Respiratory Journal, 2021

    DOI 10.1183/13993003.congress-2021.pa292 Quelle: OpenAlex

  37. Long Acting B-2 Agonists (LABA) or Anticholinergics (LAMA): Which one is more efficient in Group A COPD Patients?

    European Respiratory Journal, 2021

    DOI 10.1183/13993003.congress-2021.pa2405 Quelle: OpenAlex

  38. Her Yönüyle Tüberküloz

    AYBU AVESIS, 2020

    Quelle: OpenAlex

  39. Is ischemia modified albumin a good marker in acute exacerbation of chronic obstructive pulmonary disease?

    The European Research Journal, 2020

    DOI 10.18621/eurj.517778 Frei zugänglicher VolltextQuelle: ORCID

  40. Morphological overview of cardiovascular comorbidities in chronic obstructive pulmonary disease: Frank's sign

    Heart & Lung, 2020

    DOI 10.1016/j.hrtlng.2020.01.008 PMID 32061412 4 Zitationen (Europe PMC) Quelle: ORCID

  41. Correlatıon of neutrophyle/lymphocyte ratio and pulmonary parameters with optic coherence tomography findings in stable chronic obstructive pulmonary disease

    The Clinical Respiratory Journal, 2020

    DOI 10.1111/crj.13140 PMID 31883195 9 Zitationen (Europe PMC) Quelle: ORCID

  42. KRONİK OBSTRUKTİF AKCİĞER HASTALARINDA DİSPNE ŞİDDETİNİN DENGE ÜZERİNE ETKİLERİ

    Bozok Tıp Dergisi, 2020

    DOI 10.16919/bozoktip.546657 Frei zugänglicher VolltextQuelle: ORCID

  43. The Effect of Serum Electrolyte Disturbances and Uric Acid Level on the Mortality of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

    Turkish thoracic journal, 2020

    DOI 10.5152/turkthoracj.2019.19034 PMID 33031723 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  44. Does Nutritional Risk Screening 2002 Correlate with the Dyspnea Status of Patients with GOLD Stage C-D Chronic Obstructive Pulmonary Disease?

    Turkish thoracic journal, 2020

    DOI 10.5152/turkthoracj.2019.180194 PMID 32163364 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC

  45. Management of bleeding risk before pleural procedures: A consensus statement of Turkish respiratory society – Pleura study group

    Eurasian Journal of Pulmonology, 2020

    DOI 10.4103/ejop.ejop_28_20 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  46. Evaluation of Inflammatory Cells According to Phenotypes of Chronic Obstructive Pulmonary Disease

    Kocaeli Medical Journal, 2020

    DOI 10.5505/ktd.2020.89266 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  47. Assessment of thyroid function tests in COPD phenotypes

    European Respiratory Journal, 2020

    DOI 10.1183/13993003.congress-2020.543 1 Zitation (OpenAlex) Quelle: OpenAlex

  48. Kronik Obstrktif Akcier Hastal Fenotiplerine Gre Inflamatuar Hcrelerin Deerlendirilmesi

    Kocaeli Medical Journal, 2020

    Frei zugänglicher VolltextQuelle: OpenAlex

  49. Modifications in COPD Treatment According to GOLD Guideline Recommendations

    2020

    DOI 10.21203/rs.3.rs-15543/v1 Frei zugänglicher VolltextQuelle: OpenAlex

  50. COVİD 19’un Klinik, Labortuar ve Radyolojik Özellikleri ve Mortaliteye etki eden faktörler-TÜSAD Türkiye çalışması

    Çanakkale Onsekiz Mart University AVESIS, 2020

    Quelle: OpenAlex